A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab.
Tatli O, Oz Y, Dingiloglu B, Yalcinkaya D, Basturk E, Korkmaz M, Akbulut L, Hatipoglu D, Kirmacoglu C, Akgun B, Turk K, Pinar O, Sariyar Akbulut B, Atabay Z, Tahir Turanli E, Kazan D, Dinler Doganay G.
Tatli O, et al. Among authors: tahir turanli e.
Heliyon. 2023 Oct 31;9(11):e21001. doi: 10.1016/j.heliyon.2023.e21001. eCollection 2023 Nov.
Heliyon. 2023.
PMID: 38027967
Free PMC article.